Penserra Capital Management LLC Vanda Pharmaceuticals Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$15.69 - $21.14 $20,004 - $26,953	-1,275 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$15.35 - $21.27 $153 - $212	10 Added 0.79%	1,275 $21,000
Q2 2021 Aug 12, 2021	BUY	$15.71 - $21.51 $314 - $430	20 Added 1.61%	1,265 $27,000
Q1 2021 May 13, 2021	SELL	$13.42 - $20.28 $134 - $202	-10 Reduced 0.8%	1,245 $18,000
Q4 2020 Feb 12, 2021	BUY	$9.77 - $13.81 $7,708 - $10,896	789 Added 169.31%	1,255 $16,000
Q3 2020 Nov 13, 2020	BUY	$9.32 - $12.02 $4,343 - $5,601	466 New	466 $4,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $273M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.